Search clinical trials for: Docetaxel, nedaplatin, fluorouracil

Total 3918 results

Sun Yat-sen University
Peking University; Zhejiang Cancer Hospital; Xiangya Hospital of Central South... and other collaborators

Not yet recruiting

Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC (NX-NPC)

Nasopharyngeal Carcinoma

China
Affiliated Cancer Hospital & Institute of Guangzhou...

Recruiting

Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Affiliated Cancer Hospital & Institute of Guangzhou...

Completed

Nedaplatin in Treatment for Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Guangxi Medical University
Liuzhou Workers Hospital; Wuzhou Red Cross Hospital; Guilin Medical College; People... and other collaborators

Unknown

A Multicenter Trial Evaluating the Efficacy of Nedaplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Memorial Sloan Kettering Cancer Center
Sanofi; University of Pittsburgh; Medical College of Wisconsin; Weill Medical College... and other collaborators

Completed

Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

Gastric Cancer | Gastroesophageal Junction Adenocarcinoma

United States
The First Affiliated Hospital of Zhengzhou University
Jiangsu HengRui Medicine Co., Ltd.

Recruiting

The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC

Locally Advanced Esophageal Squamous Cell Carcinoma

China
Yun-fei Xia

Unknown

A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPC

Nasopharyngeal Carcinoma

China
Associazione Volontari Pazienti Oncologici
Mario Negri Institute for Pharmacological Research

Completed

Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (H&N07)

Head and Neck Squamous Cell Carcinoma

Italy
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Women With Breast Cancer That is Metastatic or Cannot be Treated With Surgery

Breast Cancer

United States
Jiangsu Simcere Pharmaceutical Co., Ltd.

Completed

Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell Carcinoma

Squamous Cell Carcinoma

China
Fudan University

Unknown

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage ⅣAB Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sun Yat-sen University

Recruiting

Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC

Nasopharyngeal Carcinoma | Circulating Tumor Cell | Effects of Chemotherapy | Distant Metastases.Clinical

China
Samsung Medical Center

Completed

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Hypopharyngeal Cancer

Korea, Republic of
McGill University

Completed

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

Gastric Adenocarcinoma | Esophageal Adenocarcinoma

Canada
Sanofi

Completed

Taxotere (Docetaxel) New Indication: Squamous Cell Carcinoma of the Head and Neck (SCCHN) Treatment Registration Trial

Head and Neck Neoplasms

China
Guangdong Association of Clinical Trials

Unknown

Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer

Non-Small Cell Lung Cancer

China
Northwestern University
National Cancer Institute (NCI)

Completed

Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor

Gastric Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

France, Netherlands, Spain, Poland, Belgium, Italy, Austria, Germany, Hungary, Slovakia, United Kingdom, Greece, Switzerland, Turkey, Former Yugoslavia
Shanghai Jiao Tong University School of Medicine

Recruiting

Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC

Neoplasm Neck

China
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0216, Combination Chemotherapy and RT in Treating Patients With Stage III or Stage IV Head and Neck Cancer

Head and Neck Cancer

Canada, United States
Wei Guo
Xuzhou Central Hospital

Unknown

Efficacy and Safety of Ultrasound Hyperthermia Combined With Chemotherapy on Oral and Maxillofacial-Head and Neck Cancer

Head and Neck Cancer

China
Fudan University

Unknown

Phase Ⅱ Study of Neoadjuvant Chemotherapy Followed by Concurrent Chemoradiation for Stage Ⅲ Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Sanofi

Completed

Docetaxel in Head and Neck Cancer

Head and Neck Neoplasms

Spain, Portugal
China Medical University Hospital

Completed

Biweekly TPF Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of Head and Neck

Locally Advanced Head and Neck Carcinoma
Centre Hospitalier Universitaire de Besancon

Completed

Clinical and Biological Interest of Taxanes in Advanced Squamous Cell Anal Carcinoma (Epitopes-HPV02)

Anal Canal Carcinoma

France
Thrombosis Research Institute

Completed

Overall Survival of Inoperable Gastric/GastroOesophageal Cancer Subjects on Treating With LMWH + Chemotherapy(CT) vs Standard CT (GASTRANOX)

Gastric Cancer | Gastroesophageal Cancer

India
UNICANCER

Completed

Radiation Therapy and Docetaxel With Either Fluorouracil or Cisplatin as First-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Pancreatic Cancer

France
Sun Yat-sen University

Completed

Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

China
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Completed

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

Italy
AIO-Studien-gGmbH
Neovii Biotech

Completed

Catumaxomab for Treatment of Peritoneal Carcinomatosis in Patients With Gastric Adenocarcinomas (CatuNeo)

Gastric Adenocarcinoma With Peritoneal Carcinomatosis | Siewert Type II Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis | Siewert Type III Adenocarcinoma of Esophagogastric Junction With Peritoneal Carcinomatosis

Germany
Zhejiang Cancer Hospital
Wenzhou Medical University; Second Affiliated Hospital, School of Medicine,... and other collaborators

Unknown

Efficacy Study of Neoadjuvant Chemotherapy With Chemoradiation Therapy for Nasopharyngeal Carcinoma (ESNCCT)

Nasopharyngeal Carcinoma | Chemoradiation

China
Daniela Kandioler
Medical University of Vienna; Austrian Society Of Surgical Oncology

Completed

p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer (PANCHO)

Esophageal Cancer

Austria
GERCOR - Multidisciplinary Oncology Cooperative...

Completed

Cetuximab and Combination Chemotherapy in Patients With Stage III-IV Resectable Oropharynx Cancer (ECHO-07)

Head and Neck Cancer

France
Sanofi

Completed

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Carcinoma | Nasopharyngeal Neoplasms

France, Korea, Republic of, Turkey, Algeria, Brazil, China, India, Indonesia, Italy, Mexico, Morocco, Philippines, Thailand, Tunisia
Sanofi

Completed

Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Head and Neck Neoplasms | Neoplasm Metastasis | Neoplasm Recurrence, Local

Russian Federation, United States, Canada, Germany, Hungary, Italy, South Africa, Argentina, Uruguay, Austria, Switzerland, Israel, Belgium, France, Australia, Brazil, Greece, Guadeloupe, Réunion, Spain
Wei Jiang
Wuzhou Red Cross Hospital; Guangxi Naxishan Hospital; LiuZhou People's Hospital; Guigang People's Hospital and other collaborators

Unknown

Induction Chemotherapy Followed by IMRT With or Without Concurrent Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Dana-Farber Cancer Institute
National Cancer Institute (NCI)

Completed

Combination Chemotherapy and Radiation in Treating Patients With Stage III or IV Head and Neck Cancer (Paradigm Trial)

Head and Neck Cancer

United States, Germany
Sun Yat-sen University

Unknown

Docetaxol Plus Cisplatin Versus 5-Fu Plus Cisplatin as 1st-line Chemotherapy in Advanced ESCC Patients

Esophagus Cancer | Chemotherapy Effects

China
Georgetown University

Completed

Molecularly Tailored Therapy for Pancreas Cancer

Pancreatic Cancer

United States
Federation Francophone de Cancerologie Digestive
UNICANCER; GERCOR - Multidisciplinary Oncology Cooperative Group

Active, not recruiting

PHASE III RANDOMISED TRIAL TO EVALUATE FOLFOX WITH OR WITHOUT DOCETAXEL (TFOX) AS 1st LINE CHEMOTHERAPY FOR LOCALLY ADVANCED OR METASTATIC OESOPHAGO-GASTRIC CARCINOMA (GASTFOX)

OESOPHAGO-GASTRIC CARCINOMA

France, Martinique
Radiation Therapy Oncology Group
National Cancer Institute (NCI)

Terminated

Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By Surgery

Head and Neck Cancer

United States
Spanish Cooperative Group for the Treatment of...
Sanofi; Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Combination of Cetuximab and Chemotherapy as Neoadjuvant Therapy Followed Concomitant Chemoradiotherapy Plus Cetuximab in Locoregional Esophageal Carcinoma

Esophageal Carcinoma

Spain
Hospital of Stomatology, Wuhan University
Jiangsu HengRui Medicine Co., Ltd.

Active, not recruiting

Neoadjuvant PD-1 Blockade in Resectable Oral Squamous Cell Carcinoma (NEOPBOSCC)

Oral Squamous Cell Carcinoma

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Gastric Cancer | Esophageal Cancer | Adenocarcinoma of the Gastroesophageal Junction

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S0427, Combination Chemotherapy & RT in Treating Patients With Stage III or Stage IV Cancer of the Oropharynx

Head and Neck Cancer

United States
Hokkaido Gastrointestinal Cancer Study Group
Hokkaido University Hospital

Completed

Phase I/II Study of Taxotere,CDDP and 5-FU(TPF) in Pre-treated Pts With Metastatic Esophageal Cancer.

Esophageal Cancer

Japan
Gruppo Oncologico del Nord-Ovest

Unknown

Induction Chemotherapy Followed by Cetuximab Plus Definitive Radiotherapy Versus Radiation Plus Cisplatin (INTERCEPTOR)

Squamous Cell Carcinoma of the Head and Neck

Italy
Institute of Oncology Ljubljana

Completed

Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck Cancer

Head and Neck Cancer

Slovenia
Zhejiang Cancer Hospital

Completed

S-1 Plus Nedaplatin With Concurrent Radiotherapy for Advanced Esophageal Cancer

Esophageal Cancer

China
Medical University of Lublin

Unknown

Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction

Adenocarcinoma of the Gastroesophageal Junction

Poland

Search clinical trials for: Docetaxel, nedaplatin, fluorouracil

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations